Appili Therapeutics shareholders elect six directors at annual meeting Sep 23, 2025 05:02PM
Aditxt, Inc (ADTX) Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Mar 6, 2025 08:15AM
Aditxt, Inc (ADTX) Subsidiary Pearsanta Engages Dominari Securities for its IPO Feb 21, 2025 08:15AM
Aditxt, Inc (ADTX) Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares Nov 8, 2024 08:35AM
Aditxt, Inc (ADTX) Announces 1:40 Reverse Share Split Sep 27, 2024 08:15AM


Sep 4, 2024 08:15AM Aditxt (ADTX) Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients
Aug 26, 2024 08:16AM Aditxt's (ADTX) Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President
Aug 21, 2024 08:16AM Aditxt, Inc (ADTX) Announces Third Amendment to Arrangement Agreement with Appili Therapeutics